Presentation is loading. Please wait.

Presentation is loading. Please wait.

D Mokart, Réanimation Institut Paoli-Calmettes, Marseille, France

Similar presentations


Presentation on theme: "D Mokart, Réanimation Institut Paoli-Calmettes, Marseille, France"— Presentation transcript:

1 D Mokart, Réanimation Institut Paoli-Calmettes, Marseille, France
Pourquoi la mortalité des patients d’onco-hématologie admis en réanimation diminue? D Mokart, Réanimation Institut Paoli-Calmettes, Marseille, France

2 CA Cancer J Clin. 2016 Jun 27. doi: 10.3322/caac.21351.

3 Intensive Care Med. 2014 Oct;40(10):1570-2

4 The development of more effective cancer therapies
Advances in critical care Improvements in patient selection Changes in ICU admission policies Close collaboration with hematologists and oncologists Blood Rev Nov;29(6):

5

6 Risk factors for hospital mortality
ICU mortality 27% Hospital mortality 38% 1-year mortality 57%

7 Hospital mortality (CI 95% )
Cancer ICU mortality (CI 95% ) Hospital mortality (CI 95% ) Lung 40,1% (28,6 - 52,2) 46,9% (39,9 -54,0) Oesophageal 14,7% (2,5 - 34,6) 19,9% (3,6 - 44,8) Stomach 14,6% (8,8 – 78,2) 14,6% (8,8 - 78,2) Pancreatic - 6,7% (5,1 - 46,7) Colorectal 19,2% (0 - 62,3) 35,0% (13,7 - 60,2) Breast 34,2% (15,1 - 56,4) 57,7% (42,1- 72,7) Gyneacological 8,3% (4,8 - 12,7) Head neck 34,2% (24,6 - 44,6) 54,7% (24,9 - 82,8) Urological 36,6% (25,5 - 48,4) Prostate 75,5% (36,9 - 98,6) Melanoma 95,6% (67,1 - 96,4) Overall 31,2% (24,0 - 39,0) 38,2% (33,8 - 42,7)

8 Blood Rev Nov;29(6):

9 Septic shock

10 Prognosis of septic cancer patients has improved over time

11 The impact of the surviving sepsis campaign

12

13 Intensive Care Med. 2014 Aug;40(8):1173-4

14 Hospital mortality = 43,5% (131/289 patients)
Mokart D, Slehofer G, Lambert J, Sannini A, Chow-Chine L, Brun JP, Berger P, Duran S, Faucher M, Blache JL, Saillard C, Vey N, Leone M. Intensive Care Med Jan;40(1):41-9

15 Eur J Haematol. 2016 Sep;97(3):271-7

16 Acute respiratory failure

17 Acute Respiratory Failure in Cancer Patients
Acute respiratory failure (ARF) is a frequent event Solid tumour: 5% Hematology patients: 15% Neutropenic: 30% Hematology patients at ICU admission: 62% Hospital mortality: ARF: 43% NIV: 46% IMV: 61%

18 Acute respiratory distress syndrome in patients with malignancies.
Azoulay E, Lemiale V, Mokart D, Pène F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F, Meert AP, Nyunga M, Rabbat A, Darmon M. Intensive Care Med Aug;40(8):

19 Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study. Contejean A, Lemiale V, Resche-Rigon M, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Jourdain M, Renault A, Schlemmer B, Azoulay E. Ann Intensive Care Dec;6(1):102

20 Bone Marrow Transplant. 2015 Jun;50(6):840-5.

21 Azoulay, Bone Marrow Transplantation, 2011

22

23

24 CCM 2016; 44:

25 Intensive Care Med. 2015 Nov;41(11):2008-10
Mokart D, Geay C, Chow-Chine L, Brun JP, Faucher M, Blache JL, Bisbal M, Sannini A Intensive Care Med Nov;41(11):

26 Specific situations

27

28 Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units. Toffart AC, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit JF

29 Leukostasis Pulmonary leukemic infiltration Acute lysis pneumopathy

30 Leuk Lymphoma. 2010 Feb;51(2):221-7.

31

32

33 Saillard C, Bisbal M, Sannini A, Chow-Chine L, Brun JP, Harbi S, Furst S, Blaise D, Paciencia M, Secq V, Mokart D. Eur Respir J Sep 1. pii: ERJ doi: /

34

35

36 Blood Rev Nov;29(6):

37

38

39 60% des patients avec une RxT Nle présentaient des lésions pulmonaires
Cancer Jun;19(6):

40 Leukostasis Pulmonary leukemic infiltration Acute lysis pneumopathy

41

42

43

44

45 Systematic literature review of solid cancer adult patients admitted to ICU from to April 2014 on wards using EMBASE and MEDLINE electronic databases. 48 papers identified that reported survival in ICU patients with solid cancers. ICU mortality was reported in 35 (73%) studies comprising a total sample of patients. Hospital mortality was reported in 31 (64,6%) studies across a total sample of patients.

46 Intensive Care Med. 2014 Jan;40(1):41-9.
Cumulative incidence of de-escalation = 44% Associated factors Adequation of the empirical antimicrobial treatment used in ICU [OR = 10.8 (95 % CI 1.20–96) ] for adequate documented treatment versus appropriate empirical treatment Compliance with guidelines regarding the empirical anti-pseudomonal betalactam used in ICU [OR = 10.8 (95 % CI 1.3–89.5)] Intensive Care Med Jan;40(1):41-9.

47 Surgical patients

48

49

50 J Crit Care Feb;31(1):48-53

51 Evidence for a causal link between sepsis and long-term mortality:
a systematic review of epidemiologic studies

52 Factors associated with hospital mortality :
Poorer physiological score, Invasive mechanical ventilation Poor functional status (PS >3) Oncological characteristics were not associated with mortality

53 Reasons for ICU admission Severe sepsis/ Septic shock
Acute respiratory failure Surgical patients Specific oncological situations J Clin Oncol Aug 1;31(22):


Download ppt "D Mokart, Réanimation Institut Paoli-Calmettes, Marseille, France"

Similar presentations


Ads by Google